Although Vespasiani et al. showed that low ALT was significantly associated with frailty, disability, sarcopenia, and pyridoxine deficiency, the association of low ALT and higher mortality risk remained significant after adjusting for all four confounders simultaneously. This evidence concerns the gene GPT and sarcopenia.